There is a high prevalence of chronic diseases affects lifestyle of women day-by-day. This growing demand for early stage diagnosis of infection/diseases needs new rapid diagnostic tests and imaging system which is driving growth of women’s health diagnostic test market in the near future. According to the World Health Organization (WHO), around 570,000 women died due to breast cancer in 2015. Moreover, according to the Centers for Disease Control and Prevention (CDC), around 236,968 women diagnosed with breast cancer among which around 41,211 women died in 2014.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/971
A women’s health diagnostic test is an important and necessary process for any woman of child bearing age. This type of test is required as a routine part of pre-natal care. In the event that a woman has been subjected to an unsafe sexual activity, a health test can determine if there are any sexually transmitted diseases, infections or conditions that she may have.
Increasing initiatives by health organization as a prevention measures of chronic diseases and advent of rapid diagnostic tests is propeling the market growth
In 2017, Naugatuck Valley Women’s Health Specialists (NVWHS) decided to provide a free informational program for heart health with Boston Heart Diagnostics. Boston Heart diagnostics has anticipating treatment and diagnosis of cardiovascular diseases (CVD), which improves women’s heart health, as CVD is a leading disease in the U.S. This program is expected to create awareness of CVD related diseases among women and also help to improve lifestyle.
In 2017, Mission Hope Cancer Center accredited by the National Accreditation Program for Breast Cancer Centers (NAPBC) joined Dignity Health Central Coast hospitals. In Mission Hope’s cancer care program, breast cancer examination services and facility is expected to be provided to women. Moreover, in 2017, Dignity Health installed 3D imaging technology – Mammography in the central coast. This technology helps in detection of breast cancer before symptomatic stage, which increases 98% survival rate. Thus, this program is projected to raise more awareness and early detection of cancer, which in turn is expected to augment the growth of women’s health diagnostic test market.
In 2016, Aeon Clinical Labs launched a RUO women’s health panel test, which is developed by Thermo Fischer Scientific. This test is based on PCR that detects 34 different target include candidiasis, bacterial vaginosis, and sexual transmitted diseases such as gonorrhea, chlamydia, and some others. Aeon is further aiming to expand genetic assays for pharmacogenomics and hereditary cancer in the near future.
Some of the major factors hampering the market growth include high price of diagnostic imaging system and its related procedure.
Growing prevalence of chronic diseases among women and incraesing awareness program is fueling growth of women’s health diagnostic test market
According to National Cancer Institute (NCI), in 2016, around 22,280 women diagnosed with ovary cancer and around 14,240 women died due to ovary cancer in U.S. Furthermore, according to Cancer Research UK, in 2014, around 7,378 new cases of ovary cancer and around 55,222 cases of breast cancer were diagnosed in U.K. Moreover, around 20 cases of ovarian cancers are diagnosed every day and is projected to increase by 15% by 2035.
Growing incidence and prevalence of chronic diseases among women and demand early diagnostics test are the prime factors expected to foster the growth of woman’s health diagnostics market during the forecast period.
Most of the organization and foundations are highly involved in breast cancer awareness program at local, state, and national level which include National Breast Cancer foundation, World Health Organization, and National Institute of Health and Family Welfare (NIHFW), this is expected to fuel growth of women’s health diagnostic test market during the forecast period.
Furthermore, according to the Centers for Disease Control and Prevention (CDC), in 2015, around 3,978,497 new born were estimated, which supports the increasing pregnancy cases and demand for various gestation and fertility tests and treatments, which is one of the major factors expected to propel growth of women’s health diagnostic test market in the near future.
Major players engaged in the global women’s health diagnostic test market are Biomerieux SA, F. Hoffmann-LA Roche AG, Becton, Dickinson and Company, Siemens AG, Abbott Laboratories, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Inc., GE Healthcare, and Alere Inc.
𝗖𝗵𝗿𝗶𝘀𝘁𝗺𝗮𝘀 𝗦𝗮𝗹𝗲 𝗜𝘀 𝗟𝗶𝘃𝗲!
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗧𝗼 𝗔𝘃𝗮𝗶𝗹 𝗗𝗶𝘀𝗰𝗼𝘂𝗻𝘁 𝗙𝗿𝗼𝗺 𝟮𝟱-𝟯𝟬% 𝘁𝗶𝗹𝗹 𝟯𝟭-𝗗𝗲𝗰-𝟮𝟬𝟮𝟭
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/971
Key Developments in Women’s Health Diagnostic Test Market
- In May 2019, Qiagen N.V. launched first U.S. FDA-approved companion diagnostic test, Therascreen PIK3CA Kit, for identifying breast cancer patients.
- In January 2019, Nurx Inc. launched At-Home HPV Test Kits to detect the types of human papillomavirus (HPV) that are commonly found in cervical cancer.
- In September 2018, Mira, a part of Quanovate Tech Inc, launched Mira Fertility system personalized cycle prediction by measuring fertility hormone concentrations in urine samples. The devices also helps the women to know their fertility status.
- In December 2017, Inito, a medical technology startup, launched a fertility monitor that helps women to track their ovulation days at home in an easy and convenient way. The device enables smartphones to perform lab-grade medical diagnostic tests at home using a single portable device.
- In September 2017, GE Healthcare received U.S. FDA 510 (k) clearance for it’s first-ever mammography system. The device allows women to manage their own compression during the mammography exam with the help of company’s proprietary Senographe Pristina Dueta, a remote control.
Women’s Health Diagnostic Test Market Taxonomy:
By Application
- Ovarian Cancer Test
- Diagnostic Imaging Tests
- Ovarian Cancer Tumor Marker Test
- Others
- Breast Cancer Test
- Biopsies
- Mammography
- Breast Cancer Tumor Marker Test
- Blood Chemistries and Blood Cell Count Test
- Others
- Osteoporosis Test
- Bone Densitometry
- In Vitro Blood Test
- Cervical Cancer Test
- PAP Smear
- HPV Test
- Pregnancy and Fertility Test
- Lab-Based Test
- Fertility Monitors
- Pregnancy Testing and Ovulation Prediction Kits
- Ultrasound Test
- Breast Imaging
- Obstetrics/ Gynecology Imaging
- Prenatal Genetic Screening and Carrier Test
- Cystic Fibrosis
- Torch Infections
- Down Syndrome and Edwards Syndrome
- Others
- Infectious Disease Test
- MRSA Test
- Hepatitis Test
- Tuberculosis Test
- Urinary Tract Infection Test
- Others
- Sexually Transmitted Disease (STD) Test
- HIV Test
- Chlamydia Trachomatis and Neisseria Gonorrhoeae Test
- Others
By End-user Industry
- Hospitals
- Clinics
- Diagnostic Laboratories
- Others
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/971
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Women’s Health Diagnostic Test Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Women’s Health Diagnostic Test Industry Impact
Chapter 2 Global Women’s Health Diagnostic Test Competition by Types, Applications, and Top Regions and Countries
2.1 Global Women’s Health Diagnostic Test (Volume and Value) by Type
2.3 Global Women’s Health Diagnostic Test (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Women’s Health Diagnostic Test Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Women’s Health Diagnostic Test Market Analysis
Chapter 6 East Asia Women’s Health Diagnostic Test Market Analysis
Chapter 7 Europe Women’s Health Diagnostic Test Market Analysis
Chapter 8 South Asia Women’s Health Diagnostic Test Market Analysis
Chapter 9 Southeast Asia Women’s Health Diagnostic Test Market Analysis
Chapter 10 Middle East Women’s Health Diagnostic Test Market Analysis
Chapter 11 Africa Women’s Health Diagnostic Test Market Analysis
Chapter 12 Oceania Women’s Health Diagnostic Test Market Analysis
Chapter 13 South America Women’s Health Diagnostic Test Market Analysis
Chapter 14 Company Profiles and Key Figures in Women’s Health Diagnostic Test Business
Chapter 15 Global Women’s Health Diagnostic Test Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837